Methods Participants The participants of the present study are a subcohort ( n = 60) from the TearAD study (clinicaltrails.gov: NCT05655793) 22 , a multicenter study that includes 200 participants from two memory clinics in the Netherlands, namely Maastricht University Medical Center + and the Amsterdam University Medical Center
Research overview Other vial-size protocols Related protocols and comparisons
Zalpoor H, Akbari A, Samei A, Forghaniesfidvajani R, Kamali M, Afzalnia A, et al
Emerging potential therapeutic targets of ferroptosis in skeletal diseases
In agreement with Burgess et al ., we observed a DET1 claw that embraces the Ube2e2 catalytic core on the backside -sheet, with the N-terminal Ube2e2 extension remaining flexible
For example, in the management of chronic infections, AI can detect subtle indicators of disease recurrence before clinical symptoms emerge